How DexCom Leverages AI To Tackle Diabetes

Published August 08, 2025
Larry Dignan
Editor in Chief of Constellation Insights

Executive Summary

Dexcom, which makes glucose monitoring equipment and technology, is betting that it can dramatically expand its total addressable market for people with diabetes with a big assist from generative artificial intelligence (GenAI).

Membership required to view

Already a member?
--- OR ---
Purchase this single report
$2,035.00